LncRNA uc.48+ is involved in diabetic neuropathic pain mediated by the P2X3 receptor in the dorsal root ganglia

Purinergic Signalling

Volumn 12, Issue 1, 2016, Pages 139-148

  Wang, Shouyu ^a   Xu, Hong ^a   Zou, Lifang ^a   Xie, Jinyang ^a   Wu, Hong ^a   Wu, Bing ^a   Yi, Zhihua ^a   Lv, Qiulan ^a   Zhang, Xi ^a   Ying, Mofeng ^a   Liu, Shuangmei ^a   Li, Guilin ^a   Gao, Yun ^a   Xu, Changshui ^a   Zhang, Chunping ^a   Xue, Yun ^a   Liang, Shangdong ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Diabetic neuropathic pain; Dorsal root ganglia; Long non coding RNA (lncRNA); P2X3 receptor

Indexed keywords

LONG UNTRANSLATED RNA; MITOGEN ACTIVATED PROTEIN KINASE; PURINERGIC P2X3 RECEPTOR; SMALL INTERFERING RNA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DIABETIC NEUROPATHY; ENZYME PHOSPHORYLATION; EXPERIMENTAL TEST; GENE EXPRESSION; GENE MUTATION; HUMAN; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; KNOCKOUT GENE; MALE; MECHANICAL WITHDRAWAL THRESHOLD; NEUROPATHIC PAIN; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL GANGLION; THERMAL WITHDRAWAL LATENCY; WESTERN BLOTTING; ANIMAL; BLOOD; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GENETICS; METABOLISM; NEURALGIA; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; SYNAPTIC TRANSMISSION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; GANGLIA, SPINAL; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; NEURALGIA; PAIN MEASUREMENT; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2X3; RNA, LONG NONCODING; RNA, SMALL INTERFERING; SYNAPTIC TRANSMISSION;

EID: 84957975142     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-015-9488-x     Document Type: Article

References (55)

1. Pruimboom L, van Dam AC (2007) Chronic pain: a non-use disease. Med Hypotheses 68:506–511. doi:10.1016/j.mehy.2006.08.036
2. Schmader KE, Baron R, Haanpaa ML, Mayer J, O’Connor AB, Rice AS, Stacey B (2010) Treatment considerations for elderly and frail patients with neuropathic pain. Mayo Clin Proc 85:S26–S32. doi:10.4065/mcp.2009.0646
3. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J (2008) Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70:1630–1635. doi:10.1212/01.wnl.0000282763.29778.59
4. Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311–321. doi:10.1016/j.diabres.2011.10.029
5. Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL (2012) Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol 11:521–534. doi:10.1016/S1474-4422(12)70065-0
6. Schreiber AK, Nones CF, Reis RC, Chichorro JG, Cunha JM (2015) Diabetic neuropathic pain: physiopathology and treatment. World J Diabetes 6:432–444. doi:10.4239/wjd.v6.i3.432
7. Obrosova IG (2009) Diabetes and the peripheral nerve. Biochim Biophys Acta 1792:931–940. doi:10.1016/j.bbadis.2008.11.005
8. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P (2010) Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33:2285–2293. doi:10.2337/dc10-1303
9. Davies M, Brophy S, Williams R, Taylor A (2006) The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 29:1518–1522. doi:10.2337/dc05-2228
10. Tavakoli M, Malik RA (2008) Management of painful diabetic neuropathy. Expert Opin Pharmacother 9:2969–2978. doi:10.1517/14656560802498149
11. Ponting CP, Belgard TG (2010) Transcribed dark matter: meaning or myth? Hum Mol Genet 19:R162–R168. doi:10.1093/hmg/ddq362
12. Stein LD (2004) Human genome: end of the beginning. Nature 431:915–916. doi:10.1038/431915a
13. Costa FF (2010) Non-coding RNAs: meet thy masters. Bioessays 32:599–608. doi:10.1002/bies.200900112
14. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215–233. doi:10.1016/j.cell.2009.01.002
15. Chitwood DH, Timmermans MC (2010) Small RNAs are on the move. Nature 467:415–419. doi:10.1038/nature09351
16. Louro R, Smirnova AS, Verjovski-Almeida S (2009) Long intronic noncoding RNA transcription: expression noise or expression choice? Genomics 93:291–298. doi:10.1016/j.ygeno.2008.11.009
17. Ponjavic J, Ponting CP, Lunter G (2007) Functionality or transcriptional noise? Evidence for selection within long noncoding RNAs. Genome Res 17:556–565. doi:10.1101/gr.6036807
18. Batista PJ, Chang HY (2013) Long noncoding RNAs: cellular address codes in development and disease. Cell 152:1298–1307. doi:10.1016/j.cell.2013.02.012
19. Di Gesualdo F, Capaccioli S, Lulli M (2014) A pathophysiological view of the long non-coding RNA world. Oncotarget 5:10976–10996, doi:10.18632/oncotarget.2770
20. Qureshi IA, Mehler MF (2013) Long non-coding RNAs: novel targets for nervous system disease diagnosis and therapy. Neurotherapeutics 10:632–646. doi:10.1007/s13311-013-0199-0
21. Wapinski O, Chang HY (2011) Long noncoding RNAs and human disease. Trends Cell Biol 21:354–361. doi:10.1016/j.tcb.2011.04.001
22. Sauvageau M, Goff LA, Lodato S, Bonev B, Groff AF, Gerhardinger C, Sanchez-Gomez DB, Hacisuleyman E, Li E, Spence M, Liapis SC, Mallard W, Morse M, Swerdel MR, D’Ecclessis MF, Moore JC, Lai V, Gong G, Yancopoulos GD, Frendewey D, Kellis M, Hart RP, Valenzuela DM, Arlotta P, Rinn JL (2013) Multiple knockout mouse models reveal lincRNAs are required for life and brain development. Elife 2:e1749. doi:10.7554/eLife.01749
23. Guil S, Esteller M (2015) RNA-RNA interactions in gene regulation: the coding and noncoding players. Trends Biochem Sci 40:248–256. doi:10.1016/j.tibs.2015.03.001
24. Hu W, Alvarez-Dominguez JR, Lodish HF (2012) Regulation of mammalian cell differentiation by long non-coding RNAs. EMBO Rep 13:971–983. doi:10.1038/embor.2012.145
25. Kaikkonen MU, Lam MT, Glass CK (2011) Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc Res 90:430–440. doi:10.1093/cvr/cvr097
26. Ponting CP, Oliver PL, Reik W (2009) Evolution and functions of long noncoding RNAs. Cell 136:629–641. doi:10.1016/j.cell.2009.02.006
27. Rapicavoli NA, Qu K, Zhang J, Mikhail M, Laberge RM, Chang HY (2013) A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics. Elife 2:e762. doi:10.7554/eLife.00762
28. Rinn JL, Chang HY (2012) Genome regulation by long noncoding RNAs. Annu Rev Biochem 81:145–166. doi:10.1146/annurev-biochem-051410-092902
29. Burnstock G (2006) Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58:58–86. doi:10.1124/pr.58.1.5
30. Burnstock G (2007) Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87:659–797. doi:10.1152/physrev.00043.2006
31. Burnstock G (2009) Purinergic receptors and pain. Curr Pharm Des 15:1717–1735. doi:10.1124/pr.58.1.5
32. Burnstock G (2014) Purinergic signalling: from discovery to current developments. Exp Physiol 99:16–34. doi:10.1113/expphysiol.2013.071951
33. Gao Y, Xu C, Liang S, Zhang A, Mu S, Wang Y, Wan F (2008) Effect of tetramethylpyrazine on primary afferent transmission mediated by P2X3 receptor in neuropathic pain states. Brain Res Bull 77:27–32. doi:10.1016/j.brainresbull.2008.02.026
34. Gao Y, Liu H, Deng L, Zhu G, Xu C, Li G, Liu S, Xie J, Liu J, Kong F, Wu R, Li G, Liang S (2011) Effect of emodin on neuropathic pain transmission mediated by P2X2/3 receptor of primary sensory neurons. Brain Res Bull 84:406–413. doi:10.1016/j.brainresbull.2011.01.017
35. Liang S, Xu C, Li G, Gao Y (2010) P2X receptors and modulation of pain transmission: focus on effects of drugs and compounds used in traditional Chinese medicine. Neurochem Int 57:705–712. doi:10.1016/j.neuint.2010.09.004
36. Burnstock G (2006) Purinergic P2 receptors as targets for novel analgesics. Pharmacol Ther 110:433–454. doi:10.1016/j.pharmthera.2005.08.013
37. Novakovic SD, Kassotakis LC, Oglesby IB, Smith JA, Eglen RM, Ford AP, Hunter JC (1999) Immunocytochemical localization of P2X3 purinoceptors in sensory neurons in naive rats and following neuropathic injury. Pain 80:273–282. doi:10.1016/S0304-3959(98)00225-5
38. Ueno S, Moriyama T, Honda K, Kamiya H, Sakurada T, Katsuragi T (2003) Involvement of P2X2 and P2X3 receptors in neuropathic pain in a mouse model of chronic constriction injury. Drug Dev Res 59:104–111. doi:10.1002/ddr.10208
39. Zhang A, Gao Y, Zhong X, Xu C, Li G, Liu S, Lin J, Li X, Zhang Y, Liu H, Linag S (2010) Effect of sodium ferulate on the hyperalgesia mediated by P2X3 receptor in the neuropathic pain rats. Brain Res 1313:215–221. doi:10.1016/j.brainres.2009.11.067
40. Lin J, Li G, Den X, Xu C, Liu S, Gao Y, Liu H, Zhang J, Li X, Liang S (2010) VEGF and its receptor-2 involved in neuropathic pain transmission mediated by P2X(2)(/)(3) receptor of primary sensory neurons. Brain Res Bull 83:284–291. doi:10.1016/j.brainresbull.2010.08.002
41. Burnstock G, Novak I (2013) Purinergic signalling and diabetes. Purinergic Signal 9:307–324. doi:10.1007/s11302-013-9359-2
42. Xu GY, Li G, Liu N, Huang LY (2011) Mechanisms underlying purinergic P2X3 receptor-mediated mechanical allodynia induced in diabetic rats. Mol Pain 7:60. doi:10.1186/1744-8069-7-60
43. Hanani M, Blum E, Liu S, Peng L, Liang S (2014) Satellite glial cells in dorsal root ganglia are activated in streptozotocin-treated rodents. J Cell Mol Med 18:2367–2371. doi:10.1111/jcmm.12406
44. Messinger RB, Naik AK, Jagodic MM, Nelson MT, Lee WY, Choe WJ, Orestes P, Latham JR, Todorovic SM, Jevtovic-Todorovic V (2009) In vivo silencing of the Ca(V)3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy. Pain 145:184–195. doi:10.1016/j.pain.2009.06.012
45. Xu H, Wu B, Jiang F, Xiong S, Zhang B, Li G, Liu S, Gao Y, Xu C, Tu G, Peng H, Liang S, Xiong H (2013) High fatty acids modulate P2X(7) expression and IL-6 release via the p38 MAPK pathway in PC12 cells. Brain Res Bull 94:63–70. doi:10.1016/j.brainresbull.2013.02.002
46. Liu J, Li G, Peng H, Tu G, Kong F, Liu S, Gao Y, Xu H, Qiu S, Fan B, Zhu Q, Yu S, Zheng C, Wu B, Peng L, Song M, Wu Q, Li G, Liang S (2013) Sensory-sympathetic coupling in superior cervical ganglia after myocardial ischemic injury facilitates sympathoexcitatory action via P2X7 receptor. Purinergic Signal 9:463–479. doi:10.1007/s11302-013-9367-2
47. Gunduz O, Oltulu C, Buldum D, Guven R, Ulugol A (2011) Anti-allodynic and anti-hyperalgesic effects of ceftriaxone in streptozocin-induced diabetic rats. Neurosci Lett 491:23–25. doi:10.1016/j.neulet.2010.12.063
48. Xu C, Xu W, Xu H, Xiong W, Gao Y, Li G, Liu S, Xie J, Tu G, Peng H, Qiu S, Liang S (2012) Role of puerarin in the signalling of neuropathic pain mediated by P2X3 receptor of dorsal root ganglion neurons. Brain Res Bull 87:37–43. doi:10.1016/j.brainresbull.2011.10.007
49. Barrett AM, Lucero MA, Le T, Robinson RL, Dworkin RH, Chappell AS (2007) Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med 8(Suppl 2):S50–S62. doi:10.1111/j.1526-4637.2006.00179.x
50. Tesfaye S, Selvarajah D (2012) Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev 28(Suppl- 1):8–14. doi:10.1002/dmrr.2239
51. Galer BS, Gianas A, Jensen MP (2000) Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 47:123–128. doi:10.1016/S0168-8227(99)00112-6
52. Ziegler D (2009) Painful diabetic neuropathy: advantage of novel drugs over old drugs? Diabetes Care 32(Suppl 2):S414–S419. doi:10.2337/dc09-S350
53. Stein C, Clark JD, Oh U, Vasko MR, Wilcox GL, Overland AC, Vanderah TW, Spencer RH (2009) Peripheral mechanisms of pain and analgesia. Brain Res Rev 60:90–113. doi:10.1016/j.brainresrev.2008.12.017
54. Burnstock G, Krugel U, Abbracchio MP, Illes P (2011) Purinergic signalling: from normal behaviour to pathological brain function. Prog Neurobiol 95:229–274. doi:10.1016/j.pneurobio.2011.08.006
55. Seino D, Tokunaga A, Tachibana T, Yoshiya S, Dai Y, Obata K, Yamanaka H, Kobayashi K, Noguchi K (2006) The role of ERK signaling and the P2X receptor on mechanical pain evoked by movement of inflamed knee joint. Pain 123:193–203. doi:10.1016/j.pain.2006.02.032